CI
BDSI

Cavalier Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Cavalier Investments’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-53,000
Closed -$201K – 143
2020
Q1 		$201K Hold
53,000
– – 0.12% 104
2019
Q4 		$335K Buy
+53,000
New +$312K 0.15% 110

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Cavalier Investments's BDSI Position: Q2 2020 in Review

Cavalier Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2020, closing a stake of 53,000 shares — an estimated $201K sold.

Cavalier Investments first reported a position in BDSI in Q4 2019 and held it in 2 quarters. The position peaked at $335K in Q4 2019. 158 funds tracked by Wall St. Rank hold BDSI as of Q2 2020.

  • Cavalier Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2020 after selling out during the quarter.
  • Cavalier Investments sold 53,000 BioDelivery Sciences International, Inc. shares in Q2 2020, an estimated $201K.
  • Cavalier Investments first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 2 quarters.
  • Cavalier Investments's BioDelivery Sciences International, Inc. position peaked at $335K in Q4 2019.
  • 158 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2020.

Based on Cavalier Investments's 13F filing for Q2 2020, filed 10 Aug 2020.